LifeSign 33225 Status COVID-19/Flu A&B Rapid Immunoassay for SARS-CoV-2, Influenza Type A and Type B Antigens (25 Tests per Box)

LifeSign 33225 Status COVID-19/Flu A&B Rapid Immunoassay for SARS-CoV-2, Influenza Type A and Type B Antigens (25 Tests per Box) - Contents: Status COVID-19/Flu A&B test devices (25), Extraction Reagent in capsules (25), Sterile Swabs (25), Positive Control Swab (1), Negative Control Swab (1), Package Insert /Instructions for use (1), Quick Reference Instructions (1)

• Lifesign Status COVID-19/Flu A&B Rapid Immunoassay for Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A, and Type B Antigens, 25 Tests/Box
• A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens.
• FDA Emergency Use Authorization (EUA). Visually read in 15 minutes. Flocked nasopharyngeal swab for superior specimen collection and patient comfort.
• COVID-19: Anterior nasal swab specimen − Sensitivity 93.8 %, Specificity 100%. Nasopharyngeal − Sensitivity 93.1 %, Specificity 100%. Flu A - Sensitivity 91.4%, Specificity 95.7%. Flu B - Sensitivity 87.6%, Specificity 95.9%.
• Contents: Status COVID-19/Flu A&B test devices (25), Extraction Reagent in capsules (25), Sterile Swabs (25), Positive Control Swab (1), Negative Control Swab (1), Package Insert /Instructions for use (1), Quick Reference Instructions (1)